The Adelaide professor who is taking Sygenus pain relief studies into the next phase sounds pretty upbeat about the results of the Israeli preclinical study.
We should also be getting results of the US preclinical study by the end of this week on use of Sygenus to treat an inflammatory skin condition (acne).
It's all looking very promising.
zeno9
